C86.41
Billable
Blastic NK-cell lymphoma, in remission
C86.41 is billable and can be used for reimbursement purposes.
AI Search
Analyze diagnoses and doctors notes
Blastic NK-cell lymphoma, in remission
C86.41 is billable and can be used for reimbursement purposes.